James Chao sold $82k of WLKP
Senior Chairman at Westlake Chemical Partners LP. 3,700 shares at an average of $22.10, traded May 29, 2025, filed May 30, 2025.
Score components
- +20RoleChair
- +9Trade size$82k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-079347, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 29, 2025 | SOpen-market sale Common Units | -3,700 | $22.10 | $82k | 0 | May 30, 2025 |
Related signals
Other insiders at Westlake Chemical Partners LP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | WLKPbuy Westlake Chemical Partners LP | Jean-Marc Gilson President and CEO | $2,025 95 shares | +1% | |
| 46Moderate | WLKPbuy Westlake Chemical Partners LP | Jean-Marc Gilson President and CEO | $164k 7,461 shares | +176% | |
| 28Weak | WLKPbuy Westlake Chemical Partners LP | Jean-Marc Gilson President and CEO | $7,344 320 shares | +10% | |
| 53Moderate | WLKPsell Westlake Chemical Partners LP | James Chao Senior Chairman | $226k 10,208 shares | -73% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.